Acupuncture in Treating Women With Stage I, Stage II, or Stage III Breast Cancer With Aromatase Inhibitor-Related Joint Pain
Acupuncture and Aromatase Inhibitor Related Arthralgia
Sponsor: Abramson Cancer Center at Penn Medicine
This NA trial investigates Breast Cancer and Recurrent Breast Cancer and is currently completed. Abramson Cancer Center at Penn Medicine leads this study, which shows 9 recorded versions since 2009 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Apr 2023 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — Apr 2023 [monthly]
Completed NA
-
May 2020 — Jan 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed · Phase: PHASE2 → NA
▶ Show 4 earlier versions
-
Oct 2018 — May 2020 [monthly]
Active Not Recruiting PHASE2
-
Jun 2018 — Oct 2018 [monthly]
Active Not Recruiting PHASE2
-
Feb 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE2
First recorded
May 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Abramson Cancer Center at Penn Medicine
For direct contact, visit the study record on ClinicalTrials.gov .